Mulugeta Gebregziabher to Cyclin-Dependent Kinase Inhibitor p18
This is a "connection" page, showing publications Mulugeta Gebregziabher has written about Cyclin-Dependent Kinase Inhibitor p18.
Connection Strength
0.037
-
APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke. Acta Neurol Scand. 2018 Jan; 137(1):133-141.
Score: 0.037
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.